2025-01-01 2025-12-31 2025-12-31 false 11569681 513 Lordship Lane Limited 68209Other letting and operating of own or leased real estate iso4217:GBP xbrli:pure 115696812025-01-01 115696812025-12-31 115696812025-01-01 2025-12-31 11569681bus:SmallEntities2025-01-01 2025-12-31 11569681bus:AuditExempt-NoAccountantsReport2025-01-01 2025-12-31 11569681bus:FullAccounts2025-01-01 2025-12-31 11569681core:WithinOneYear2025-12-31 11569681core:AfterOneYear2025-12-31 11569681core:WithinOneYear2025-01-01 2025-12-31 11569681core:AfterOneYear2025-01-01 2025-12-31 11569681core:CurrentFinancialInstruments2025-12-31 11569681core:Non-currentFinancialInstruments2025-12-31 11569681core:CurrentFinancialInstruments2025-01-01 2025-12-31 11569681core:Non-currentFinancialInstruments2025-01-01 2025-12-31 11569681core:LandBuildings2025-01-01 2025-12-31 11569681core:FurnitureFittings2025-01-01 2025-12-31 11569681core:OfficeEquipment2025-01-01 2025-12-31 11569681core:Vehicles2025-01-01 2025-12-31 11569681core:PlantMachinery2025-01-01 2025-12-31 11569681core:OtherPropertyPlantEquipment2025-01-01 2025-12-31 11569681core:LandBuildings2025-12-31 11569681core:PlantMachinery2025-12-31 11569681core:Vehicles2025-12-31 11569681core:FurnitureFittings2025-12-31 11569681core:OfficeEquipment2025-12-31 11569681core:OtherPropertyPlantEquipment2025-12-31 11569681core:Right-of-useAssets2025-01-01 2025-12-31 11569681core:Right-of-useAssets2025-12-31 11569681core:Goodwill2025-01-01 2025-12-31 11569681core:PatentsTrademarksLicencesConcessionsSimilar2025-01-01 2025-12-31 11569681core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-01 2025-12-31 11569681core:OtherResidualIntangibleAssets2025-01-01 2025-12-31 11569681core:Goodwill2025-12-31 11569681core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-12-31 11569681core:PatentsTrademarksLicencesConcessionsSimilar2025-12-31 11569681core:OtherResidualIntangibleAssets2025-12-31 11569681dpl:CostSales2025-01-01 2025-12-31 11569681dpl:AdministrativeExpenses2025-01-01 2025-12-31 11569681dpl:DistributionCosts2025-01-01 2025-12-3111569681core:ShareCapital2025-12-31 11569681core:SharePremium2025-12-31 11569681core:RevaluationReserve2025-12-31 11569681core:OtherReservesSubtotal2025-12-31 11569681core:ShareCapitalPreferenceShares2025-12-31 11569681core:CapitalRedemptionReserve2025-12-31 11569681core:OtherCapitalReserve2025-12-31 11569681core:RetainedEarningsAccumulatedLosses2025-12-3111569681core:ShareCapital2025-01-01 2025-12-31 11569681core:SharePremium2025-01-01 2025-12-31 11569681core:RevaluationReserve2025-01-01 2025-12-31 11569681core:OtherReservesSubtotal2025-01-01 2025-12-31 11569681core:RetainedEarningsAccumulatedLosses2025-01-01 2025-12-311156968112025-01-01 2025-12-31 1156968122025-01-01 2025-12-3111569681core:ShareCapital12025-01-01 2025-12-31 11569681core:ShareCapital22025-01-01 2025-12-3111569681core:SharePremium12025-01-01 2025-12-31 11569681core:SharePremium22025-01-01 2025-12-3111569681core:RevaluationReserve12025-01-01 2025-12-31 11569681core:RevaluationReserve22025-01-01 2025-12-3111569681core:RetainedEarningsAccumulatedLosses12025-01-01 2025-12-31 11569681core:RetainedEarningsAccumulatedLosses22025-01-01 2025-12-311156968112025-01-01 2025-12-3111569681core:Non-currentFinancialInstrumentscore:CostValuation2025-01-01 11569681core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-31 11569681core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3111569681core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-31 11569681core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-12-31 11569681core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3111569681core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-01-01 11569681core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-31 11569681core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-31 11569681core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-31 11569681core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-12-31 11569681core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-31 11569681core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-12-3111569681core:Non-currentFinancialInstruments2025-12-31 11569681core:Non-currentFinancialInstruments2024-12-31115696812024-01-01 115696812024-12-31 115696812024-01-01 2024-12-31 11569681core:WithinOneYear2024-12-31 11569681core:AfterOneYear2024-12-31 11569681core:CurrentFinancialInstruments2024-12-31 11569681core:Non-currentFinancialInstruments2024-12-31 11569681core:LandBuildings2024-12-31 11569681core:PlantMachinery2024-12-31 11569681core:Vehicles2024-12-31 11569681core:FurnitureFittings2024-12-31 11569681core:OfficeEquipment2024-12-31 11569681core:OtherPropertyPlantEquipment2024-12-31 11569681core:Right-of-useAssets2024-12-31 11569681core:Goodwill2024-12-31 11569681core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-31 11569681core:PatentsTrademarksLicencesConcessionsSimilar2024-12-31 11569681core:OtherResidualIntangibleAssets2024-12-31 11569681dpl:AdministrativeExpenses2024-01-01 2024-12-3111569681core:ShareCapital2024-12-31 11569681core:SharePremium2024-12-31 11569681core:RevaluationReserve2024-12-31 11569681core:OtherReservesSubtotal2024-12-31 11569681core:ShareCapitalPreferenceShares2024-12-31 11569681core:CapitalRedemptionReserve2024-12-31 11569681core:OtherCapitalReserve2024-12-31 11569681core:RetainedEarningsAccumulatedLosses2024-12-3111569681core:RetainedEarningsAccumulatedLosses2024-01-01 11569681core:ShareCapital2024-01-01 11569681core:SharePremium2024-01-01 11569681core:RevaluationReserve2024-01-01 11569681core:ShareCapital2024-01-01 2024-12-31 11569681core:SharePremium2024-01-01 2024-12-31 11569681core:RevaluationReserve2024-01-01 2024-12-31 11569681core:OtherReservesSubtotal2024-01-01 2024-12-31 11569681core:RetainedEarningsAccumulatedLosses2024-01-01 2024-12-311156968112024-01-01 2024-12-31 1156968122024-01-01 2024-12-3111569681core:ShareCapital12024-01-01 2024-12-31 11569681core:ShareCapital22024-01-01 2024-12-3111569681core:SharePremium12024-01-01 2024-12-31 11569681core:SharePremium22024-01-01 2024-12-3111569681core:RevaluationReserve12024-01-01 2024-12-31 11569681core:RevaluationReserve22024-01-01 2024-12-3111569681core:RetainedEarningsAccumulatedLosses12024-01-01 2024-12-31 11569681core:RetainedEarningsAccumulatedLosses22024-01-01 2024-12-3111569681bus:Director12025-01-01 2025-12-3111569681bus:Director22025-01-01 2025-12-3111569681bus:PrivateLimitedCompanyLtd2025-01-01 2025-12-31
513 Lordship Lane Limited
Unaudited Financial Statements
for the year ended 31 December 2025
Company registration number 11569681
(England and Wales)

Company Information

For the year ended 31 December 2025
Directors Egan, Colm Michael
Flook, Robert James

Registered office 13 Raeburn Avenue
Surbiton
KT5 9BN

Registered number 11569681

Accountant CH4 Accounts Limited
13 Raeburn Avenue
SURBITON
Surrey
KT5 9BN

Statement of Financial Position

As at 31 December 2025
Notes
2025
2024
£
£
£
£
Fixed assets
Investment property
1,350,000
-
1,350,000
-
Current assets
Stocks
5
-
1,275,496
Debtors
6
2,518
1,970
Cash at bank and in hand
16,731
11,485
19,249
1,288,951
Creditors
Amounts falling due within one year
7
(1,279,070)
(1,259,635)
(1,279,070)
(1,259,635)
Net current assets (liabilities)
(1,259,821)
29,316
Total assets less current liabilities
90,179
29,316
Net assets (liabilities)
90,179
29,316
Capital and reserves
Called up share capital
100
100
Revaluation reserve
74,504
-
Profit and loss account
15,575
29,216
Total equity
90,179
29,316

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 21 September 2026 and are signed on its behalf by:

Flook, Robert James
Flook, Robert James
Director

Company registration number 11569681

Notes to the Financial Statements

For the year ended 31 December 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales

taxes.


Revenue includes amounts receivable on sale of properties net of VAT, with a sale being recognised on completion.


Rent receivable is recognised in the period for which it relates to. Rent is measured as the fair value of the consideration receivable, net of VAT and is recognised in Other operating income.

2.3. Finance costs

Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets until such time as the assets are substantially ready for their intended use or sale.

2.4. Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

2.5. Current taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.


The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

2.6. Investment property

Investment property is carried at fair value determined annually by the director and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset. No depreciation is provided. Changes in fair value are recognised in profit or loss.

2.7. Financial instruments

Election and recognition

The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.


Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.


Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due within the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.


Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss.


If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.


Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.


Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

2.8. Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost comprises expenditure incurred directly in developing the stocks to their current condition.


At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

2.9. Trade and other debtors

Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

2.10. Trade and other creditors

Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

2.11. Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

2.12. Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

3. Employees

The average number of employees during the year was 2 (2024: 2).

4. Investment property

Valuation
£
Fair value adjustments
74,504
Transfers to/(from) inventories
1,275,496
At 31 December 2025
1,350,000

The directors noted that the expected change in the market for the type of property held had not occurred and concluded that the Company now intended to hold the property to earn rental income. As such, the property has been transferred from Stock to Investment Property and is now carried at fair value.

5. Stocks

2025
2024
£
£
Finished goods
-
1,275,496
Total
-
1,275,496

6. Debtors

2025
2024
£
£
Trade debtors
1,450
1,400
Other debtors
560
75
Prepayments and accrued income
508
495
Total due within one year
2,518
1,970
Total due after one year
-
-
Total
2,518
1,970

7. Creditors due within one year

2025
2024
£
£
Trade creditors
8
178
Other creditors
1,230,911
1,230,743
Taxation and social security
36,451
17,252
Accruals and deferred income
11,700
11,462
Total
1,279,070
1,259,635